Abbott Laboratories (TSX:ABT)

Market Cap	264.29B -18.1%
Revenue (ttm)	60.78B +5.7%
Net Income	8.95B -51.3%
EPS	5.10 -51.3%
Shares Out	n/a
PE Ratio	29.55
Forward PE	19.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	307
Average Volume	5,421
Open	20.12
Previous Close	19.92
Day's Range	19.80 - 20.12
52-Week Range	18.73 - 22.79
Beta	1.05
RSI	43.54
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Software - Application
• Sector: Technology
• Founded: 1888
• Employees: 115,000
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2025, Abbott Laboratories's revenue was $44.33 billion, an increase of 5.67% compared to the previous year's $41.95 billion. Earnings were $6.52 billion, a decrease of -51.13%.

Financial numbers in USD